Finance Fusion💲
@Fusion_100x
Followers
2K
Following
4K
Media
785
Statuses
3K
CFA L1 Cleared 💼 Market-Obsessed 🚀 Microcap Hunter ||Politics and Finance 🤓|| ⚠️ Not SEBI Registered
India
Joined May 2021
🚀 Next 10x Candidate? Sagility India Ltd: A silent multibagger emerging from India’s IT–healthcare BPM space. Debt-free, strong earnings, AI adoption, and institutional buying spree. Let’s decode this hidden gem. 👇
1
3
6
Silver Rush 2.0 is here ETF premiums exploding 7–18% above NAV, ₹1,300+ Cr turnover in a day! Physical supply lag + smart money rotation from gold → silver = liquidity squeeze. This isn’t a rally it’s a momentum melt-up turning silver from a hedge into a hype asset.
0
0
2
Time to short 🫡
0
3
4
Nifty ATH coming?
"I am speaking to President Putin now. The conversation is ongoing, a lengthy one, and I will report the contents, as will President Putin, at its conclusion." - President Donald J. Trump
0
3
4
Written prophecy of Silver ETFs 🤣
@KhungarSanjiv Supply crunch. High etf premium. Inflated price
1
3
5
💬 Analyst Take: If Sagility sustains 20%+ growth with 25%+ margins, This could be a 2x story in 2–3 years. Healthcare BPM is evergreen, recession-proof & AI-friendly. ⚠️ Not a reco. But Sagility India Ltd looks like the kind of quiet compounder that turns into a multi-bagger
0
1
5
📈 Technical Inflection: 30 EMA > 180 EMA = early trend reversal 🔄 Strong fundamentals + technical breakout = perfect storm forming 🌪️ 🔥 FY26 Q1 Update: Revenue ↑25.8% YoY → ₹1,538 Cr PAT ↑566% YoY → ₹149 Cr EBITDA margin: 24% BroadPath integration successful.
1
0
4
⚙️ Why It’s Special: ✅ Strong AI and automation focus ✅ Healthcare digitization tailwinds ✅ US outsourcing boom ✅ Debt-free + strong cash flow ✅ High institutional confidence
1
0
1
🏦 Big Moves: Acquired US-based BroadPath → expanded client base Institutional investors (Canara Robeco etc.) buying heavy Promoters released all pledged shares EPS expected to jump 37% in FY26 PEG ~0.10 👀 undervalued vs growth
1
0
1
📊 FY25 Performance: Revenue: ₹5,570 Cr (↑17%) EBITDA: ₹1,470 Cr (↑28%) PAT: ₹540 Cr (↑137%) Debt down 66% EBITDA margin 26% In Q4, profit literally doubled. 💥
1
0
1
💡 What Sagility Does: It’s a healthcare-focused digital operations company serving US insurers & hospitals. Think automation + analytics + AI for healthcare claims, billing, and member engagement. 40,000+ employees | 30+ centers | 5 countries 🌍
1
0
2
We’re now in the 15-year Cycle that favors Commodities over Stocks
0
4
7
Started😒😒
Booking 75% holding rest
1
3
6
STALLION INDIA – Q2FY26 Results Snapshot Solid turnaround on all fronts | strong operating leverage Key Highlights: ✦ Revenue: ₹105 Cr ⬆️ from ₹67 Cr YoY ✦ EBITDA: ₹15.5 Cr ⬆️ from ₹2 Cr YoY ✦ EBITDA Margin: 14.8% ⬆️ from 2.8% YoY ✦ Net Profit: ₹11.4 Cr ⬆️ from
Stallion India Fluorochemicals is gearing up for a big leap! 6 plants by 2025 (R32, helium, specialty gases) 30–35% CAGR growth target PAT margins set to rise from ~10% → 17–18% ₹2,500 Cr turnover goal by 2030 First mover in India’s HFO market. Read: https://t.co/po9LXZX166
1
3
6
If the Court allows it, this could set a terrifying precedent using judicial power to sanitize scam-linked assets under the guise of commercial viability. Justice or convenience? A special 3-judge bench will now decide. ⚖️ #Adani #Sahara #SupremeCourt
0
2
5
That means even if ED, SFIO or tax probes prove fraud later these assets stay untouchable. ⚠️ Basically, a “clean slate” transfer of assets built with public money while ₹1 lakh+ crore remains stuck in depositor claims.
1
2
5
🚨 Adani–Sahara Deal: A Legal Earthquake in the Making 🚨 Adani Group is reportedly eyeing 88 Sahara assets, but Sahara wants the Supreme Court to invoke Article 142 granting total immunity from all past, present & future legal claims. 👀
1
4
6